carbenoxolone sodium has been researched along with Epilepsy, Temporal Lobe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehnicke, C; Deisz, RA; Devaux, B; Gigout, S; Louvel, J; Pumain, R; Turak, B | 1 |
| Armand, V; Avoli, M; D'Antuono, M; Devaux, B; Gigout, S; Kawasaki, H; Kurcewicz, I; Laschet, J; Louvel, J; Olivier, A; Pumain, R; Turak, B | 1 |
2 other study(ies) available for carbenoxolone sodium and Epilepsy, Temporal Lobe
| Article | Year |
|---|---|
Role of gap junctions on synchronization in human neocortical networks.
Topics: Adult; Benzamides; Carbenoxolone; Cortical Synchronization; Epilepsy, Temporal Lobe; Female; Gap Junctions; Humans; Male; Neocortex; Neuroglia; Proline | 2016 |
Effects of gap junction blockers on human neocortical synchronization.
Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Brain Diseases; Carbenoxolone; Child; Cortical Synchronization; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agents; Gap Junctions; Humans; Membrane Potentials; Middle Aged; Neocortex; Octanols; Organ Culture Techniques; Potassium Channel Blockers; Quinidine; Quinine; Receptors, GABA; Receptors, N-Methyl-D-Aspartate | 2006 |